DOD Spinal Cord Injury Research Program Translational Research Award
ID: 353179Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353179
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the FY24 Spinal Cord Injury Research Program (SCIRP) Translational Research Award. This grant aims to support innovative translational research that accelerates the application of promising spinal cord injury (SCI) research into clinical settings, focusing on improving health outcomes for military personnel and veterans affected by SCIs. The program has allocated an estimated total of $10.32 million to fund approximately five awards, with a strong emphasis on collaborative approaches that involve community stakeholders and individuals with lived SCI experiences. Interested applicants must submit pre-applications by May 20, 2024, followed by full applications due by August 30, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524SCIRPTRA-GG.pdf
    The Department of Defense (DOD) has released a funding opportunity for the FY24 Spinal Cord Injury Translational Research Award under the Congressionally Directed Medical Research Programs. This initiative aims to support innovative research that advances the diagnosis, treatment, and management of spinal cord injuries (SCIs) affecting military personnel and veterans. The program has earmarked $40 million for research to improve health outcomes in individuals living with SCIs, with a focus on maintaining spinal cord integrity at injury, validating biomarkers, enhancing quality of life via psychosocial support, and rehabilitation improvements. Applicants must outline their approach to translational research by identifying current and future scientific landscapes, along with the next steps post-research. Additionally, collaborative approaches with community stakeholders, including those with lived SCI experience, are mandated to ensure research relevance and impact. The application process involves a two-step submission; pre-applications are due by May 20, 2024, with full applications expected by August 30, 2024. The anticipated funding is contingent upon the merit and quality of submitted applications. This program underscores the DOD’s commitment to advancing SCI research benefiting service members, veterans, and their families.
    Similar Opportunities
    DoD VRP, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Vision Translational Research Award (VRP TRA) to support innovative translational research aimed at advancing the prevention, diagnosis, and treatment of eye injuries and visual dysfunction associated with military service. This grant opportunity encourages projects that establish a clear path for transforming promising discoveries into clinical applications, including new drugs and devices, with a focus on collaboration with regulatory experts to facilitate the approval process. With an estimated total program funding of $1.6 million and the expectation of one award, interested applicants must submit a pre-application by July 11, 2024, followed by a full application by November 8, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD VRP, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is offering the FY24 Vision Clinical Trial Award to fund innovative clinical trials aimed at addressing eye injuries and visual dysfunctions related to military service. This grant opportunity supports early-phase clinical trials that evaluate new products, pharmacologic agents, and devices, with a focus on improving treatment outcomes for service-connected visual impairments. With an estimated total program funding of $2.56 million and an anticipated award amount of up to $1.6 million per application, interested applicants must submit their pre-applications by July 11, 2024, and full applications by November 8, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Toxic Exposures Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Toxic Exposures Translational Research Award (TRA) to support research on adverse health outcomes related to military toxic exposures. This grant aims to facilitate translational research that bridges basic science and clinical applications, focusing on developing diagnostics, treatment strategies, and understanding exposure mechanisms to improve health care for service members and their families. With an estimated total program funding of $12.8 million and the expectation of awarding six grants, applicants must submit a pre-application by August 13, 2024, followed by a full application due by November 7, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Disability and Rehabilitation Research Projects (DRRP) Program: Research on Non-Traumatic Spinal Cord Injury
    Active
    Administration for Community Living
    The Administration for Community Living is forecasting a grant opportunity under the Disability and Rehabilitation Research Projects (DRRP) Program, focusing on research related to non-traumatic spinal cord injury. The objective of this grant is to enhance the effectiveness of services authorized under the Rehabilitation Act by generating new knowledge and developing methods and technologies that improve outcomes for individuals with disabilities, particularly those with significant support needs. This initiative is crucial for advancing rehabilitation practices and understanding the experiences of affected individuals. The grant has an estimated total funding of $500,000, with a project period of 60 months, and interested applicants can reach out to Brian Bard at 202-795-7298 or via email at Brian.Bard@acl.hhs.gov for further details. Key deadlines include an estimated synopsis post date of February 11, 2025, and a close date of April 11, 2025.
    DoD VRP, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Vision Research Program (VRP) Investigator-Initiated Research Award, aimed at advancing research on eye injuries related to military service. This grant opportunity seeks innovative proposals that address the understanding, prevention, diagnosis, and treatment of eye injuries associated with military exposure, with two funding levels available to accommodate projects at different stages of maturity. The program emphasizes the importance of improving care for service members and veterans affected by visual injuries, with an estimated total funding of $832,000 and the expectation of awarding approximately seven grants. Interested applicants must submit a pre-application by July 11, 2024, followed by a full application due by November 8, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Disability and Rehabilitation Research Projects (DRRP) Program: Research on Resilience and Positive Mental Health Outcomes Among People with Spinal Cord Injury
    Active
    Administration for Community Living
    The Administration for Community Living is offering a federal grant opportunity under the Disability and Rehabilitation Research Projects (DRRP) Program, focusing on research related to resilience and positive mental health outcomes among individuals with spinal cord injuries. The objective of this grant is to generate new knowledge and develop methods that enhance the effectiveness of services for people with disabilities, particularly those with significant support needs. This initiative is crucial for advancing rehabilitation technologies and improving overall outcomes for individuals affected by spinal cord injuries. The grant has an award ceiling of $500,000 and a project period of 60 months, with applications due by April 14, 2025. Interested applicants can reach out to Brian Bard at 202-795-7298 or via email at Brian.Bard@acl.hhs.gov for further information.
    DoD VRP, Focused Translational Team Science Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Focused Translational Team Science Award (FTTSA) under the Vision Research Program (VRP) to advance research on eye injuries and visual dysfunction resulting from military exposure. This grant aims to foster collaborative research initiatives that address significant gaps in understanding, prevention, and treatment of eye trauma, with applications required to include three to five synergistic research projects that align with the program's focus areas. With an estimated total program funding of $6.4 million and a maximum budget of $4 million per project, the opportunity is open to unrestricted applicants, and full applications are due by November 8, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Toxic Exposures Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Toxic Exposures Clinical Trial Award under the Toxic Exposures Research Program (TERP). This grant aims to support the rapid implementation of clinical trials that address health outcomes related to military-related toxic exposures, with a focus on prevention, treatment, and management of associated symptoms and diseases. The program emphasizes the importance of collaboration between the Department of Defense and the Department of Veterans Affairs, seeking proposals that align with specific program goals and topic areas, such as neurotoxin exposure and Gulf War Illness. The total estimated funding for this initiative is $10.4 million, with applications due by November 7, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    DOD Glioblastoma, Resource Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Glioblastoma Resource Development Award, aimed at enhancing research capabilities for glioblastoma, a malignant brain tumor. This grant supports the development of preclinical model systems that improve the understanding and treatment of glioblastoma, with a focus on innovative approaches such as animal models, organoids, and patient-derived xenografts. With a total funding pool of $4 million, the program anticipates awarding up to five grants, each capped at $500,000 over three years. Interested applicants must submit a pre-application by November 6, 2024, followed by a full application due by November 20, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.